BAC vs PACB Stock Comparison

BAC currently leads PACB in this stock comparison, with AIQ scores of 56 vs 48. The clearest difference is risk resilience, while PACB has the stronger momentum profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 8 points
BAC
Financial Services
vs
PACB
Healthcare
BAC
Bank of America Corporation
Leads
Price
$48.91
Day move
-1.07%
AIQ Score
56/100
Best edge
Risk Resilience
Sector
Financial Services
PACB
Pacific Biosciences of California, Inc.
Price
$1.83
Day move
+0.55%
AIQ Score
48/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and PACB?

BAC leads the current stock comparison as Bank of America Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Pacific Biosciences of California, Inc.

Data as of Nov 18, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 5/10

BAC leads

BAC leads by 8 AIQ points, primarily on Risk Resilience and Value, but the lead has narrowed from 18 points over 30 sessions.

Fragile: 4 of 6 evidence groups support BAC, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Weakening
BAC

Bank of America Corporation

Leads
AIQ Score
56/100
AIQ Edge Score
6/10
PACB

Pacific Biosciences of California, Inc.

AIQ Score
48/100
AIQ Edge Score
4/10

The Algovestiq AIQ Score currently favors BAC over PACB, 56 versus 48 as of Nov 18, 2026. BAC's advantage is driven primarily by stronger risk resilience and value, while PACB holds the stronger momentum profile. BAC also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor BAC today, and the comparison is rated Fragile on stability: the leader's advantage has been narrowing. BAC lead: Weakening — the AIQ differential moved from 18 to 8 points over 30 sessions.

Compare Bank of America Corporation and Pacific Biosciences of California, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+19.5%
PACB
-91.9%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $11,945 · PACB $807

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and PACB against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
PACB advantage
  • Risk Resilience83 vs 24
    BAC +59
  • Momentum34 vs 84
    PACB +50
  • Value65 vs 23
    BAC +42
  • Quality64 vs 32
    BAC +32

4 of 6 evidence groups favor BAC. BAC’s edge is concentrated in risk resilience and value; PACB keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

BAC-1 AIQ

Largest factor move: Value -3

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
PACB0 AIQ

Largest factor move: Value -1, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.56x)
  • Stochastic Oversold Bounce — bullish, momentum, short horizon

BAC's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and PACB both carry a full feed there.

The central trade-off

BAC (Bank of America Corporation): the stronger current systematic profile, led by risk resilience and value.

PACB (Pacific Biosciences of California, Inc.): the counter-case, on momentum, fundamentals, technicals — but at materially higher volatility, 114.1% against 24.8%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BAC

BAC on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PACB

PACB on combined revenue and EPS growth.

Value

BAC

BAC on the peer-relative Value factor, by 42 points.

Momentum

PACB

PACB on the Momentum factor, by 50 points.

Lower downside

BAC

BAC on Risk Resilience, by 59 points.

Analyst upside

BAC

BAC on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBACPACBNote
Implied upside to target+29.4%+5.2%BAC has more room
Target dispersion+25.3%+59.7%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering258Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor BAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBAC56 vs 48
FundamentalsPACBon balancerevenue growth -3.3% vs 4%; EPS growth -23.8% vs 14.3%; TTM ROE 2.3% vs 61.7%; gross margin 60.4% vs 34.5%; operating margin 22.4% vs -99.6% — PACB takes 3 of 5 decided legs, not all of them
ValuationBACValue 65 vs 23
TechnicalsPACBPrice vs 50-day -9.5% vs -8.7%; vs 200-day -7% vs 22.4%
Risk ResilienceBACRisk Resilience 83 vs 24
Analyst expectationsBACTarget upside 29.4% vs 5.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and PACB and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 8 points.
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BAC.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

BAC lead: Weakening — the AIQ differential moved from 18 to 8 points over 30 sessions.

Jun 1BAC leads above the line · PACB leads belowNov 18
Today
BAC +8
56 vs 48
7 sessions ago
BAC +9
58 vs 49
30 sessions ago
BAC +18
62 vs 44
90 sessions ago
BAC +40
70 vs 30

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
PACBConflicted

3 bullish / 3 bearish / 1 neutral, conflicted

Only PACB

  • Golden Cross Active — bullish, trend, long horizon (25.22%)
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (14.16%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.56x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • Stochastic Oversold Bounce — bullish, momentum, short horizon

BAC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -1.07%, AIQ -1 points).

PACBNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.55%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PACB closes the Risk Resilience gap — currently 59 points behind, the largest single contributor to BAC's edge.
  2. 2PACB's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 10 points over 30 sessions, and a further 8-point move would eliminate BAC's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PACB leads on balance
MetricBACPACB
Revenue growth (YoY)-3.3%4%
EPS growth (YoY)-23.8%14.3%
Gross margin60.4%34.5%
Operating margin22.4%-99.6%
Return on equity (TTM)2.3%61.7%
Debt to equity1.28-11.49

Performance

PACB leads 5 of 6 windows
MetricBACPACB
1 week (5 sessions)3.2%-13.1%
1 month (20 sessions)-0.4%13.3%
3 months (63 sessions)-20.1%62%
6 months (126 sessions)2.5%75%
Year to date-7.2%4.8%
1 year (252 sessions)-5.7%12.6%

Technicals

PACB has the stronger structure
MetricBACPACB
RSI (14)45.943.1
ADX (14)27.227.4
Price vs 50-day-9.5%-8.7%
Price vs 200-day-7%22.4%
Volatility (1M, annualized)24.8%114.1%

Risk

BAC is the more resilient
MetricBACPACB
Beta0.792.1
Sharpe ratio-0.220.61
Sortino ratio-0.290.96
Max drawdown-23.7%-58.4%
Current drawdown-21.3%-32.4%
Annualized volatility22.4%93.5%
Value at risk (95%)-2.6%-9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or PACB?

On the Algovestiq AIQ Score, BAC is the stronger of the two as of Nov 18, 2026, scoring 56 against PACB's 48. The edge comes from risk resilience and value. PACB is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or PACB the better buy right now?

BAC carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the leader's advantage has been narrowing. Treat the lead as provisional.

Why does the AIQ Score favor BAC over PACB?

The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Risk Resilience by 59 points; PACB leads Momentum by 50 points; BAC leads Value by 42 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or PACB?

Analyst price targets imply +29.4% upside for BAC and +5.2% for PACB, so the Street currently favors BAC. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or PACB?

BAC is the better-valued of the two on the peer-relative Value factor. BAC on the peer-relative Value factor, by 42 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or PACB?

PACB on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or PACB?

PACB on the Momentum factor, by 50 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or PACB?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 59 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than PACB?

The profitability evidence is mixed: gross margin 60.4% vs 34.5%; operating margin 22.4% vs -99.6%; ttm roe 2.3% vs 61.7%. BAC leads on two measures and PACB on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is BAC's lead over PACB getting stronger or weaker?

BAC lead: Weakening — the AIQ differential moved from 18 to 8 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.

What would change the BAC vs PACB verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PACB closes the Risk Resilience gap — currently 59 points behind, the largest single contributor to BAC's edge; PACB's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 10 points over 30 sessions, and a further 8-point move would eliminate BAC's advantage entirely.

What do the current signals say about BAC and PACB?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. PACB: 3 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On PACB it is Golden Cross Active (bullish, long horizon).

Compare BAC and PACB with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.